CH538459A - Verfahren zur Herstellung von in 3-Stellung unsubstituierten 1,4-Steroiden - Google Patents

Verfahren zur Herstellung von in 3-Stellung unsubstituierten 1,4-Steroiden

Info

Publication number
CH538459A
CH538459A CH578367A CH578367A CH538459A CH 538459 A CH538459 A CH 538459A CH 578367 A CH578367 A CH 578367A CH 578367 A CH578367 A CH 578367A CH 538459 A CH538459 A CH 538459A
Authority
CH
Switzerland
Prior art keywords
preparation
steroids
unsubstituted
steroids unsubstituted
Prior art date
Application number
CH578367A
Other languages
English (en)
Inventor
John Foell Theodore
Wilhelm Rees Richard
Smith Herchel
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of CH538459A publication Critical patent/CH538459A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
CH578367A 1966-04-25 1967-04-24 Verfahren zur Herstellung von in 3-Stellung unsubstituierten 1,4-Steroiden CH538459A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54480066A 1966-04-25 1966-04-25
US62246867A 1967-03-13 1967-03-13

Publications (1)

Publication Number Publication Date
CH538459A true CH538459A (de) 1973-06-30

Family

ID=27067737

Family Applications (1)

Application Number Title Priority Date Filing Date
CH578367A CH538459A (de) 1966-04-25 1967-04-24 Verfahren zur Herstellung von in 3-Stellung unsubstituierten 1,4-Steroiden

Country Status (12)

Country Link
US (1) US3574196A (de)
JP (1) JPS495335B1 (de)
BE (1) BE697544A (de)
CH (1) CH538459A (de)
DE (1) DE1618058B1 (de)
DK (2) DK127727B (de)
ES (1) ES339707A1 (de)
FR (2) FR1529732A (de)
GB (2) GB1192062A (de)
IL (1) IL27840A (de)
NL (1) NL6705803A (de)
SE (2) SE362073B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5135937U (de) * 1974-09-06 1976-03-17
JPS5135936U (de) * 1974-09-06 1976-03-17

Also Published As

Publication number Publication date
FR1529732A (fr) 1968-06-21
GB1192062A (en) 1970-05-20
GB1192061A (en) 1970-05-20
DK127727B (da) 1973-12-24
DE1793749B2 (de) 1975-07-24
DE1618058B1 (de) 1972-07-13
ES339707A1 (es) 1968-05-16
SE362073B (de) 1973-11-26
BE697544A (de) 1967-10-02
JPS495335B1 (de) 1974-02-06
US3574196A (en) 1971-04-06
FR8354M (de) 1971-02-08
DK128208B (da) 1974-03-18
SE342237B (de) 1972-01-31
DE1793749A1 (de) 1973-05-03
IL27840A (en) 1972-04-27
NL6705803A (de) 1967-10-26

Similar Documents

Publication Publication Date Title
CH494222A (de) Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
CH507200A (de) Verfahren zur Herstellung von 3,4-Dihydroxyphenylalkanolaminen
AT271479B (de) Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen
CH481924A (de) Verfahren zur Herstellung von 6-Aminophenyl- und 6-Acylaminophenyl-4,5-dihydropyridazonen (3)
CH449011A (de) Verfahren zur Herstellung von 2,3-Pyridindiol
CH487096A (de) Verfahren zur Herstellung von 4,4'-Dohydroxy-stilbenen
CH481935A (de) Verfahren zur Herstellung von N-Acyl-3,4-dihydrooxazinen-(1,3)
CH506548A (de) Verfahren zur Herstellung von 2-aminsubstituiertem 4,5-Diphenyl-Oxazol
CH472429A (de) Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten
CH540896A (de) Verfahren zur Herstellung von 15,16B-Methylensteroiden
AT275060B (de) Verfahren zur Herstellung von 1β-Hydroxy-5-oxo-4-(2'-carboxy-äthyl)-7aβ-R-3aα-4β,5,6,7,7a-hexahydroindanen
CH490299A (de) Verfahren zur Herstellung von Diaryl-8-methoxy-1,2,3,4-tetrahydro-1,2-naphthalindiolen
CH538459A (de) Verfahren zur Herstellung von in 3-Stellung unsubstituierten 1,4-Steroiden
CH489525A (de) Verfahren zur Herstellung von 1,8-Naphthyridinderivaten
AT259771B (de) Verfahren zur Herstellung von 6,7-Benzomorphanen
CH490342A (de) Verfahren zur Herstellung von 2,6-Dicyan-4-nitranilin
CH493545A (de) Verfahren zur Herstellung von Derivaten von 1,2,3,4-Tetrahydro-5H-pyrido-(4,3b)-indolen
CH478211A (de) Verfahren zur Herstellung von Azophthalocyanin-Reaktivfarbstoffen
CH483434A (de) Verfahren zur Herstellung von 1,2-Dihydrobenzodiazepinen
AT266800B (de) Verfahren zur Herstellung von 2-Thiapropandiol-(1,3)
CH498118A (de) Verfahren zur Herstellung von 2-Amidino-1,2,3,4-tetrahydroisochinolinen
AT292662B (de) Verfahren zur Herstellung von 1,1'-Peroxydicyclohexylamin
AT306711B (de) Verfahren zur Herstellung von in 3-Stellung unsubstituierten 2-Nitrobenzofuranen
CH492692A (de) Verfahren zur Herstellung von 15a-Halogen-14B-hydroxycard-20(22)-enoliden
CH556369A (de) Verfahren zur herstellung von anthrachinonfarbstoffen.

Legal Events

Date Code Title Description
PL Patent ceased